Embed Size (px)
Citation preview
Brain & Behavior Research Foundation30th Anniversary Celebration
Celebrating ourPardes Humanitarian Prizewinners and
Outstanding Achievement Prizewinners
FRIDAY, OCTOBER 27th
The Pierre
INTERNATIONAL AWARDS DINNER
2017
Welcome to our 2017 International Awards Dinner and our celebration of the 30th anniversary of the
Brain & Behavior Research Foundation. This year’s program honors our 2017 Outstanding Achieve-
ment Prizewinners, the recipient of the Pardes Humanitarian Prize in Mental Health, and, includes a
special Pardes Humanitarian Prize Honorary Tribute to the late Constance E. Lieber, whose leadership
as President and President Emeritus of our Foundation, touched so many lives. Connie was one of the
world’s greatest public advocates for mental health and psychiatric research and care and she continues
to be our guiding light.
This year’s Pardes Humanitarian Prize honors Doctors Without Borders/Médecins San Frontières (MSF)
for their transformative work in providing mental health care as an integrated component of medical
aid during natural and man-made emergencies and chronic crises. Founded in 1971, MSF provides aid
in nearly 60 countries and received the 1999 Nobel Peace Prize for its independent, rapid, and fearless
work during humanitarian catastrophes.
Bestowed annually since 2014, the Pardes Prize recognizes a person(s) or organization whose human-
itarian work is transformative and of great magnitude, changing the lives and bringing the joy of living
to those facing challenges to mental health. The Prize focuses public attention on the burden of mental
illness on individuals and on society, and the urgent need to expand and enhance mental health services
both in the developed world and in developing countries. The Prize was named in honor of Dr. Herbert
Pardes, the first recipient of the award. One of Dr. Pardes’ many contributions to our field has been his
founding and continued leadership of the Brain & Behavior Research Foundation’s Scientific Council, a
volunteer group of 177 pre-eminent mental health professionals across disciplines in brain and behavior
research, who select Foundation Grantees from more than 1,200 grant applications each year.
Nine innovative and exceptional scientists—many of them Foundation Grantees—will also be honored this
evening for their contributions to the advancement of our understanding and treatment of schizophrenia,
bipolar disorder, anxiety, trauma, and child and adolescent psychiatry. Their work is distinguished by their
use of cutting-edge technology and a devotion to finding personalized therapies that will improve our
care for those living with mental illness, as well as seeking preventive and diagnostic tools for the future.
We are delighted to have you here to celebrate the impactful progress being made in brain and behav-
ior research. Our shared commitment to scientific advancement will change what it means to live with a
mental illness and pave the way for more people to live full, happy and productive lives.
Thank you for your ongoing support. Enjoy the evening!
Sincerely,
Jeffrey Borenstein, M.D.
President & CEO
Brain & Behavior Research Foundation
WELCOME
4 Board of Directors and Dinner Committee Sponsors and Contributors
8 Pardes Humanitarian Prize in Mental Health
Honoree : Doctors Without Borders/Médecins Sans Frontières (MSF) Honorary Tribute : Constance E. Lieber
11 O U T S TA N D I N G AC H I E V E M E N T PRIZ E S
Lieber Prize for Schizophrenia Research
John M. Davis, M.D. University of Illinois at Chicago
12 Maltz Prize for Innovative & Promising Schizophrenia Research
Deanna L. Kelly, Pharm.D., BCPP University of Maryland School of Medicine
13 Colvin Prize for Mood Disorders Research
Hilary P. Blumberg, M.D. Yale School of Medicine
Tadafumi Kato, M.D., Ph.D. RIKEN Brain Science Institute, Japan
Mary L. Phillips, M.D., M.D. (Cantab) University of Pittsburgh, Western Psychiatric Institute and Clinic
16 Ruane Prize for Child & Adolescent Psychiatric Research
Nathan A. Fox, Ph.D. The University of Maryland, College Park
Charles A. Nelson III, Ph.D. Harvard Medical School & Boston Children’s Hospital
Charles H. Zeanah, Jr., M.D. Tulane University School of Medicine
19 Goldman-Rakic Prize for Cognitive Neuroscience
Trevor W. Robbins, Ph.D. University of Cambridge, UK
20 Previous Outstanding Achievement Prizewinners
24 Scientific Council
4
board of directors
President & CEOJeffrey Borenstein, M.D.
President, Scientific CouncilHerbert Pardes, M.D.
OFFICERS
ChairmanStephen A. Lieber
Vice PresidentAnne E. Abramson
SecretaryJohn B. Hollister
TreasurerArthur Radin, CPA
DIRECTORSCarol A. Atkinson
Eric Bam
Donald M. Boardman
J. Anthony Boeckh
Susan Lasker Brody, MPH
Suzanne Golden
Bonnie D. Hammerschlag
John Kennedy Harrison II
Carole H. Mallement
Milton Maltz
Marc R. Rappaport
Virginia M. Silver
Kenneth H. Sonnenfeld, Ph.D., J.D.
Barbara K. Streicker
Barbara Toll
Robert Weisman, Esq.
dinner committee
Anne and Ronald Abramson
Carol Atkinson
Patricia and Eric Bam
Janet and Donald Boardman
Raymonde and J. Anthony Boeckh
Jeffrey Borenstein, M.D.
Susan Lasker Brody, MPH
Suzanne and John Golden
Bonnie and Alan Hammerschlag
Marla Press and Ken Harrison
Kathy and John Hollister
Stephen A. Lieber
Carole and Harvey Mallement
Tamar and Milton Maltz
Miriam Katowitz and Arthur Radin, CPA
Léa Dartevelle and Marc R. Rappaport
Virginia and Mark Silver, M.D.
Kenneth Sonnenfeld, Ph.D, J.D.
Barbara and John Streicker
Barbara Toll
Frances and Robert Weisman, Esq.
5
Supporters
GALAXYAlpine Woods Capital Investors, LLC
Borrego Foundation, Inc.
Lieber Family
COSMIC Tamar and Milton Maltz
CELESTIALNewYork-Presbyterian
STARAnne and Ronald Abramson Family Foundation
Graham Boeckh Foundation
Bonnie and Alan Hammerschlag
Columbia University
King & Spalding LLP
Joan M. Leiman, M.D.
BENEFACTORJanina and Andrew Boral, M.D.
AMBASSADORGNYHA Ventures, Inc.
Virginia and Mark Silver, M.D.
VIPJayamin and Dhruvika Patel Amin
Marina Benaur, M.D. and Marc Dubin
Janet and Donald Boardman
Collins Building Services, Inc.
Léa Dartevelle and Marc Rappaport
Maria and Dan Doyle
Beth Elliott
Rita and Robert Gadsden
Suzanne and John Golden
Horizon Group Properties, Inc.
Lou Innamorato
Miriam Katowitz and Arthur Radin
Ann and Rob Laitman
Joan and Gregg Popkin
Lilian Sicular
Elizabeth Stumbo and Stephen Taylor
Janet Susin
Barbara Toll
Weill Cornell Medicine
INDIVIDUALLinda Bauer
Louisa Benton
Susan Lasker Brody, MPH
Joanne and George Bundschuh
Lillian Clagett
Daniels Family Foundation Inc.
Rose DiMartino
Annikki Elkind
Gloria & Hilliard Farber Foundation
Benjamin Haskin
Bonnie Becker Krystal, M.D. and John Krystal, M.D.
JSquared Press, Inc.
Jill and Sanford Sirulnick
University of Pittsburgh
The John L. & Sue Ann Weinberg Foundation
Ann Weiner
Marni Zabel and Gerry Modell
HONOR ROLLWallace Currey
Ellyn Roth and Harold Pincus, M.D.
Carol Trager and Matthew Carrano
6
This international Prize recognizes a physician, sci-
entist, organization, or public citizen whose extraor-
dinary contribution has made a profound and lasting
impact by improving the lives of people suffering from
mental illness and by advancing the understanding
of mental health. Established in 2014, the Pardes
Humanitarian Prize in Mental Health was named in
honor of Dr. Herbert Pardes, the first recipient of
the award.
Bestowed annually, the Prize recognizes a person(s)
or organization whose humanitarian work is trans-
formative and of great magnitude, changing lives and
bringing the joy of living to those facing challenges to
mental health. Nominations are solicited worldwide;
the recipient of the Prize is chosen by a distinguished
Committee of eleven members and receives an hon-
orarium. The Pardes Humanitarian Prize in Mental
Health focuses public attention on the burden of
mental illness on individuals and society. It also recog-
nizes the urgent need to expand and enhance mental
health services in both the developed world and devel-
oping countries.
No one has better described the goals of this interna-
tional Prize than Dr. Pardes himself: “Mental illness is
the largest single health challenge in the world. For
many decades society has recognized major contri-
butions in basic science, clinical research and clinical
care in the non-psychiatric health fields. The Pardes
Humanitarian Prize has been established to honor
individuals who comprehensively care, teach, inves-
tigate, work and passionately advocate for improv-
ing the mental health of society, and who have had
a powerful impact on reducing the pain inflicted by
psychiatric illness.”
Rendering of The Pardes Humanitarian Prize medal
featuring Hygeia, Goddess of Health.
Pardes Humanitarian PRIZE
in mental health
dr. herbert pardes
7
Herbert Pardes, M.D.Executive Vice Chairman of the Board of Trustees NewYork-Presbyterian Hospital
Celso Arango, M.D., Ph.D.Head of Child and Adolescent Psychiatry Service Hospital General Universitario Gregoria Maranon, Madrid
Jack D. Barchas, M.D.Chair, Department of Psychiatry Weill Cornell Medical College
Psychiatrist-in-Chief NewYork-Presbyterian Hospital
William T. Carpenter, Jr., M.D.Professor of Psychiatry and PharmacologyDirector, Maryland Psychiatric Research Center University of Maryland School of Medicine
Robert R. Freedman, M.D.Professor and Chairman, Department of Psychiatry University of Colorado School of Medicine
Dilip V. Jeste, M.D.Associate Dean for Healthy Aging and Senior Care Estelle and Edgar Levi Chair in Aging
Distinguished Professor of Psychiatry and Neurosciences
Director, Sam and Rose Stein Institute for Research on AgingUniversity of California, San Diego
Helen S. Mayberg, M.D.Professor of Psychiatry, Neurology, and Radiology
Dorothy C. Fuqua Chair in Psychiatric Neuroimaging and Therapeutics Emory University School of Medicine
Vikram Patel, Ph.D., F.Med.Sci.Pershing Square Professor of Global Health and Wellcome Trust Principal Research Fellow
Department of Global Health and Social Medicine Harvard Medical School.
Judith L. Rapoport, M.D.Chief, Child Psychiatry Branch National Institute of Mental Health (NIMH/NIH)
Norman Sartorius, M.D., Ph.D., F.R.C.Psych.President,Association for the Improvement of Mental Health Programmes Geneva, Switzerland
Myrna M. Weissman, Ph.D.Diane Goldman Kemper Professor of Epidemiology and Psychiatry
Chief, Division of Epidemiology Columbia University College of Physicians and Surgeons New York State Psychiatric Institute
Pardes Humanitarian PRIZE select ion committee
8
Doctors Without Borders/Médecins Sans Frontières
(MSF) provides emergency medical aid in response to
armed conflicts, natural disasters, famines, and epidem-
ics. MSF doctors and nurses are often seen treating
physical ailments: bandaging the war-wounded, rehy-
drating a cholera patient, or performing an emergency
cesarean section. But for more than 20 years, MSF has
also been providing vital psychiatric and psychological
care to people ravaged by man-made or natural disas-
ter. The organization currently has mental health related
programs in 41 countries across five continents treating
adults and children.
Violence, armed conflict, disease outbreaks, natural
disasters, sexual violence, and neglect can be profoundly
traumatic for individuals who live through them and can
lead to severe mental health issues both in the moment
and beyond. Depression and anxiety can immobilize
people at just the time when they need to take action
for themselves and their families. MSF intervenes where
there is a lack of mental health services in areas afflicted
by natural and man-made disasters, and as a support to
other medical activities.
The first MSF mental health interventions were in
Armenia in 1990 after the earthquake. In the 1990s, MSF
initiated mental health programs in Gaza, the Balkans and
in Eastern Europe, and in 1998, MSF formally recognized
the need to implement mental health and psychosocial
interventions as part of their emergency work.
Since then, the scope of interventions originally tailored
towards survivors of disasters has been broadened to
include more and more integrated activities within medical
programs. Today, MSF considers providing mental health
care a primary objective in a variety of contexts. Mental
Health and Psychosocial Support (MHPSS) is necessary
and relevant during natural and man-made emergencies,
during chronic crises, and as an integrated component of
medical care. Mental health care increases the efficacy
of medical treatments, and is an important component
of programs focused on treating HIV/AIDS, tuberculosis,
malnutrition, and non-communicable diseases.
MSF mental health programs now reach tens of thousands
worldwide. Among them are Syrian children at a hospital
in northern Jordan, typhoon survivors in the Philippines,
survivors of sexual violence in Haiti, cholera victims in
Yemen, and displaced people across the globe, includ-
ing Iraq, Lebanon, Italy, Mexico, Tanzania, and Sudan.
Recognizing that the long-term psychological impact of
humanitarian crises are frequently underestimated or
undertreated, MSF plans to expand its mental health pro-
grams around the globe.
Through their tremendous work at the frontlines, in often
dangerous and volatile areas of the world, the physicians,
nurses and staff of MSF provide an unwavering example
of what it truly means to be a humanitarian.
Pardes Humanitarian PRIZE in mental health
Photo credit : Ton Koene
awarded to:
doctors without borders
/Medecins Sans Frontieres
9
Honorary Pardes Humanitarian PRIZE in mental health
Constance E. Lieber transformed her family’s expe-
rience with mental illness into a lifetime of extraordi-
nary advocacy and support for psychiatric research of
schizophrenia, depression, and other mental illnesses.
She was unwavering in her dedication to alleviating
the suffering caused by mental illness and banishing
the stigma that for too long has been associated with
psychiatric disorders.
It was over 30 years ago at a symposium at Columbia
University when Dr. Herbert Pardes first met Connie
Lieber and her husband Stephen Lieber. They spoke
with him about supporting mental health programs
and research on mental illness. That conversation has
led to $380 million in grants from the Brain & Behavior
Research Foundation to more than 4,500 of the most
innovative scientists around the world.
Connie Lieber served as President of the Brain &
Behavior Research Foundation, formerly known as the
National Alliance for Research on Schizophrenia and
Depression (NARSAD) from 1989 to 2007. She then
continued to provide leadership as President-Emer-
ita until 2016. Under her leadership, the Foundation
became a major global institution in mental health and
psychiatric research. She and Steve through their lead-
ership and generosity transformed the private sector
with their support for psychiatric research.
Connie Lieber was a global champion for mental health
and an extraordinary humanitarian. Not only did she
work tirelessly to support scientists in the field, but
guided by her own personal experience and compas-
sion, she informally advised thousands of parents who
were desperately seeking help for their children.
Married for over 66 years, Connie and Steve Lieber
were dedicated partners, leading the way in public
advocacy and philanthropic support of psychiatric
research. At Columbia University, they founded two
centers of excellence–the Lieber Recovery and Reha-
bilitation Clinic and the Lieber Center for Schizophre-
nia Research and Treatment. At Williams College,
they were the founders of the undergraduate neu-
roscience program. In 2011, they created the Lieber
Institute for Brain Development, affiliated with Johns
Hopkins University.
For her extraordinary and enduring legacy of generos-
ity, brilliance and compassion, which has inspired others
to improve the lives of people suffering from mental
illness, we honor Constance E. Lieber.
awarded to:
constance E. lieber
10
Outstanding Achievement Prizes for 2017
Tonight we celebrate the transformative power of neuroscience and psychiatric research to improve the lives of those with mental illness. Nine exceptional scientists, selected by the Brain & Behavior Research Foundation’s Scientific Council, will be honored for their outstanding lifetime achievements in brain and behavior science.
The Outstanding Achievement Prizes are awarded annually and include the:
Lieber Prize for Schizophrenia ResearchEstablished in 1987 by Constance and Stephen Lieber to bring
public recognition to the outstanding discoveries being made in
schizophrenia research. This prize carries an award of $50,000.
Maltz Prize for Innovative & Promising Schizophrenia ResearchEstablished in 2004, the prize was formerly known as the Baer
Prize and was renamed in 2016 in honor of Board Members
Milton and Tamar Maltz. The Maltz Prize provides $40,000 to
an investigator who has undertaken innovative and promising
research in schizophrenia. Winners of this prize are selected
by the Lieber Prize recipient(s) of the same year.
The Outstanding Achievement Prizewinners are dedicated
teachers and scientists who represent models of accomplish-
ment for younger scientists in brain and behavior research.
Colvin Prize for Mood Disorders ResearchEstablished in 1993, this prize was formerly known under the
successive titles of the Selo Prize, Falcone Prize, and Bipolar
Mood Disorders Prize. The prize was renamed in 2012 in honor
of the late Oliver D. Colvin, Jr., a great benefactor of the Foun-
dation who left the largest single contribution in the Founda-
tion’s history. This prize carries an award of $50,000.
Ruane Prize for Childhood & Adolescent Psychiatric ResearchThis prize was initiated in 2000 by philanthropists Joy and
William Ruane to recognize important advances in understand-
ing and treatment of early-onset brain and behavior disorders.
This prize carries an award of $50,000.
Goldman-Rakic Prize for Cognitive NeuroscienceThis prize was created by Constance and Stephen Lieber in
memory of Patricia Goldman-Rakic, Ph.D., a distinguished neu-
roscientist renowned for discoveries about the brain’s frontal
lobe, after her tragic death in an automobile accident in 2003.
The prize carries an award of $40,000.
Scientific Council Prize Committees
Lieber PrizeWilliam E. Bunney, Jr., M.D. (Chair)
Arvid E. Carlsson, M.D.
Kenneth S. Kendler, M.D.
Philip Seeman, M.D., Ph.D.
Carol Tamminga, M.D.
Daniel R. Weinberger, M.D.
Colvin PrizeRobert M. Post, M.D. (Chair)
Wade Berrettini, M.D., Ph.D.
William E. Bunney, Jr., M.D.
Jan A. Fawcett, M.D.
Frederick K. Goodwin, M.D.
Robert M.A. Hirschfeld, M.D.
Husseini K. Manji, M.D.
Ruane Prize
Judith L. Rapoport, M.D. (Chair)
Joseph T. Coyle, M.D.
Rachel G. Klein, Ph.D.
James E. Leckman, M.D.
Daniel Pine, M.D.
Goldman-Rakic PrizeJack D. Barchas, M.D. (Chair)
Huda Akil, Ph.D.
Jonathan D. Cohen, M.D., Ph.D.
Paul Greengard, Ph.D.
Bruce S. McEwen, Ph.D.
Michael I. Posner, Ph.D.
Solomon H. Snyder, M.D., Ph.D., DSc
Leslie G. Ungerleider, Ph.D.
11
l ieber PRIZE For Outstanding Achievement in Sch izophren ia Research
John M. Davis attended Princeton Univer-
sity, received his medical degree from Yale
University School of Medicine, interned
at Massachusetts General Hospital, and
went back to Yale for his psychiatric res-
idency. He received his research training
at the National Institute of Health. He is
now in the department of psychiatry at
the University of Illinois at Chicago School
of Medicine.
Dr. Davis did the first studies of how anti-
psychotic drugs are metabolized in the
body and how this process may impact
their efficacy and side effects. His work
showed that the therapeutic doses were
much lower than previously thought. His
early research also included work on the
involvement of the neurotransmitter
dopamine in schizophrenia, leading to the
development of partial dopamine blockers
as antipsychotic drugs.
Among his other accomplishments, Dr.
Davis wrote the first science-based text-
book on psychopharmacology as a guide
for psychiatrists seeking to use medica-
tions more effectively. In 1975, he also
performed the first meta-analysis study
in psychiatry (the second in medicine).
Meta-analyses use mathematical tech-
niques to summarize data from multiple
clinical trials. Dr. Davis’ first meta-anal-
ysis provided convincing evidence that
maintenance antipsychotic, mood stabi-
lizers and antidepressant drugs could help
prevent future schizophrenic episodes.
Dr. Davis has also studied nutrition and
his work on the role of adequate dietary
intake of omega-3 fatty acids has resulted
in changes to the FDA guidelines and the
2015 Dietary Guidelines for Americans.
Dr. Davis currently studies gene expres-
sion abnormalities in schizophrenia and
conducts clinical trials addressing the
disease. He has been a member of numer-
ous national scientific advisory com-
mittees and editorial boards, and is the
recipient of several awards including the
American College of Psychiatrists’ Stanley
Dean Award for Research in Schizophre-
nia for 2006.
Gilman Professor of Psychiatry and Research
Professor of Medicine University of Illinois at Chicago
john m. davis, M.D.“I am profoundly humbled to join the alumni of recipients of the
Lieber Prize for Schizophrenia Research. I particularly want to acknowledge and honor the generosity of Constance and Stephen Lieber for whom the award is named. Advances in schizophrenia research in the 30 years since the award was established are exponential and linked definitively to their support and that of the Brain & Behavior Research Founda-tion. Clinical scientists form a bridge between basic research and the patient and can translate clinical findings or obser-vations back to the basic scientists. My hope for this award is to serve as a stimulus to encourage more clinicians towards clinical research.”
“Lieber Prize Selection Committee Chairman Dr. William Bunney, said Davis “has a long, extremely distinguished career involving pioneering work relevant to the etiology and treatment of schizo-phrenia. He performed the first meta-analysis in psychiatry on the prevention of relapse in schizo-phrenia with maintenance anti-psychotics, the first determinations of anti-psychotic plasma levels and their drug interactions, and wrote the first science-based textbook in psychiatry.”
”
12
Professor University of Maryland Schoolof Medicine
Affiliate Professor University of Maryland School of Pharmacy
Director, Treatment Research Program Maryland Psychiatric Research Center
Deanna L. Kelly is Professor of Psychia-
try at University of Maryland Baltimore
School of Medicine and Affiliate Pro-
fessor in the School of Pharmacy. She is
currently Director and Chief of the Treat-
ment Research Program at the Maryland
Psychiatric Research Center. Dr. Kelly
received her bachelor’s and doctoral
degrees in pharmacy, at Duquesne Uni-
versity. She completed residency training
in psychiatric pharmacy practice at the
University of Maryland.
Dr. Kelly’s research focuses on treatment
research, mostly conducting clinical trials
with innovative treatment targets and for
understudied populations. Dr. Kelly has
completed one of the few large clinical
trials in women with schizophrenia, and
she runs a unique large multinational trial
to improve outcomes with clozapine treat-
ment in people of African descent. She has
completed a handful of unique studies in
specific schizophrenia subgroups and she
is running the only inpatient clinical trial
focusing on the removal of dietary gluten
in people with schizophrenia who have
antibodies to the gluten protein, gliadin.
The overarching goal of her research is to
help develop personalized and beneficial
treatments to enable people with schizo-
phrenia to have access to potentially life
altering treatments.
Dr. Kelly has co-authored or authored 16
books and book chapters and has pub-
lished more than 160 peer-reviewed
manuscripts. She serves as a founding
and current Associate Editor for Clinical Schizophrenia and Related Psychoses, is a
member of the American College of Neu-
ropsychopharmacology and currently is
the President for the College of Psychi-
atric and Neurologic Pharmacists.
Deanna L. Kelly, Pharm.D., BCPp“The Brain & Behavior Research Foundation is the
premier organization worldwide truly committed to funding innovative projects and science in the mental health arena. It has impacted and inspired countless young scientists around the globe, undoubtedly shaping the early years of many prominent thought leaders in the field. To receive recognition for my work from this organization is humbling and I am truly honored and privileged to be a recipient of the Maltz Prize for Inno-
vative & Promising Schizophrenia Research.”
“John M. Davis, M.D., the 2017 recipient of the Lieber Prize, said Dr. Kelly “is truly one of the few clinical scientists who investigate basic phenomena at the level of the person with schizophrenia. Academia-based clinical trial work, asking important questions and studying important outcomes by applying novel treatments and targets, is few and far between. She has completed many important clinical trials that have helped shape the way the field views personalized medicine in a translational clinical trial framework. Her most recent clinical trial work in women is commendable and her work studying people with gluten antibodies is remarkable and exciting, helping to shape new treatments and studying new mechanisms, for a subgroup with schizophrenia.”
”
maltz PRIZE
For Innovat ive & Promis ing Sch izophren ia Research
13
Hilary P. Blumberg is the John and Hope
Furth Professor of Psychiatric Neurosci-
ence, Professor of Psychiatry, Radiology
and Biomedical Imaging and Faculty at
the Child Study Center at the Yale School
of Medicine. She is Director of the Yale
Mood Disorders Research Program that
brings together scientists from multiple
disciplines across the campus to study
mood and related disorders. She gradu-
ated summa cum laude in neuroscience
from Harvard University and completed
her medical degree, psychiatry training
and specialty training in research in neu-
roimaging of neuropsychiatric disorders at
Cornell University Medical College.
Dr. Blumberg is an international leader in
research in bipolar disorder (BD) in chil-
dren, adolescents, and adults. Among her
important pioneering contributions was
one of the first demonstrations of brain
differences in individuals while experi-
encing manic symptoms of BD. She and
her team subsequently showed brain
differences in individuals experiencing
depression, and differences present
during asymptomatic times that may place
them at risk for episodes. She has used
innovative, integrative approaches with
neuroimaging to show negative influences
of genetic variations and early life stress
(such as child abuse and neglect), and sal-
utary influences of pharmacological and
non-pharmacological interventions, on
the structure and function of the brain’s
circuitry related to emotional processing.
Dr. Blumberg is perhaps best known
for her pioneering work in these areas
of research in youths with BD. This has
included research evidence of differ-
ences in the trajectories of develop-
ment of the brain circuitry during ado-
lescence that has shaped the view of
BD as a disorder of neurodevelopment
and of adolescence as an important
period. Her more recent areas of study
include some of the first multi-modality
research on the brain circuitry of suicide
risk in adolescents and young adults, as
well as changes in the brain in BD with age
later in life, and with her Brain Emotion
Circuitry-Targeted Self-Monitoring and
Regulation Therapy (BE-SMART) psy-
chobehavioral treatment. Dr. Blumberg’s
research brings great hope that on the
horizon are new methods for early detec-
tion, targeted treatments, improved prog-
nosis, and prevention of BD progression
and suicide.
John and Hope Furth Endowed Professor of Psychiatric Neuroscience
Professor of Psychiatry, Radiology and Biomedical Imaging
Faculty Child Study Center Director, Mood Disorders Research Program Yale University School of Medicine
Scientific Council Member
2006 Klerman Prize for Exceptional Clinical Research
2006 Independent Investigator2002 Young Investigator
Hilary P. Blumberg, M.D.
“Receiving the Colvin Award is a peak of my research career – at each stage, BBRF has provided the support critical to propel me to the next through the Young and Independent Investigator pro-grams, and deeply meaningful Klerman Award. I am humbled to receive the Colvin and will do my very best to honor it by accelerating on the research course to reduce suffering from mental illness and
training the next generation of young investigators.”
“Robert M. Post, M.D., Chair of the Colvin Prize Selection Committee, said Dr. Blumberg “was the first to research and identify structural and functional brain differences in adolescents with bipolar disorder, impli-cating both gray and white matter as targets for bipolar disorder preventive and treatment interventions. She is currently a leading member of a new international consortium that is forming to study suicide in affective disorders. With her expertise and enthusiasm, her mentorship has been transformative in the development of young researchers focused on study of affective disorders.”
”
COLV IN PRIZE
For Outstanding Achievement In Mood D isorders Research
14
Senior Team Leader, Laboratory for Molecular Dynamics of Mental Disorders
Deputy DirectorRIKEN Brain Science Institute
2008, 2000 Independent Investigator
Tadafumi Kato is a Senior Team Leader
and the Deputy Director of RIKEN Brain
Science Institute. He received an M.D.
from the University of Tokyo, with resi-
dency training at the University of Tokyo
Hospital. He received his Ph.D. from Shiga
University of Medical Science, where he
began his work on magnetic resonance
spectroscopy in bipolar disorder and
identified impaired energy metabolism
in the brain.
In studying the neurobiology of bipolar
disorder, Dr. Kato found that mitochon-
drial DNA deletions were accumulated
in the postmortem brains of bipolar
patients. Using model mice that have
accumulated mitochondrial DNA dele-
tions in the brain, Dr. Kato’s research
team has found that the mice show
recurrent spontaneous depression-like
episodes which responded to lithium,
and has identified a region of the brain
involved in these episodes. This would
be the first animal model of spontaneous
recurrent depression-like episodes that
would be potentially useful for develop-
ment of mood stabilizers. The local mito-
chondrial dysfunction was verified in the
postmortem brains of patients with mito-
chondrial disease with mood symptoms.
Dr. Kato’s series of work has established
the role of mitochondrial dysfunction in
bipolar disorder.
His research group has also been working
on genomic analyses of bipolar disorder,
publishing one of the first comprehen-
sive analyses of transcribed genes in
the postmortem brains of patients with
bipolar disorder. Since then, he and his
colleagues have applied similar technol-
ogies to clinical samples and also animal
models to find dysfunctional mechanisms
within bipolar disorder and related dis-
orders. The studies have revealed the
role of a type of cellular stress in mono-
zygotic twins discordant for bipolar dis-
order, the role of a genetic element called
retrotransposon LINE-1 in schizophrenia,
and de novo (newly generated) mutations
related to bipolar disorder.
Tadafumi Kato, M.D., Ph.D.
COLV IN PRIZE For Outstanding Achievement In Mood D isorders Research
“I have been dedicated to the study of bipolar disorder for nearly three decades. I think that we have made substantial progress in these decades. In spite of the progress, I regret that our neurobiological findings of bipolar disorder have not yet changed the clinical practice. When I mainly con-centrated on clinical practice in the past, feedback from patients encouraged me every day. On the other hand, it takes many years for patients to benefit from the outcome of neurobiological research, and thus basic researchers rarely feel rewarded for their effort. Being awarded the Colvin Prize, a prestigious prize focusing on mood disorder research, has encouraged me to pursue this difficult but meaningful research for the rest of my life.”
“Robert M. Post, M.D., Chair of the Colvin Prize Selection Committee, said Kato’s significant accom-plishments include the verification of mitochondrial dysfunction in postmortem brains of patients with mitochondrial disease with mood symptoms, and the creation of the first animal model of spontaneous recurrent depression-like episodes. “Dr. Kato has vastly improved our knowledge of the causes of the disorder, created hope for patients and families and inspired many scientists at all levels.”
”
15
Mary L. Phillips is the Pittsburgh Foun-
dation-Emmerling Endowed Chair in
Psychotic Disorders, and Professor in
Psychiatry and Clinical and Translational
Science in the University of Pittsburgh.
She heads the Clinical and Translational
Affective Neuroscience Program in the
Department of Psychiatry at the Univer-
sity of Pittsburgh. Dr. Phillips trained in
Medicine at Cambridge University, UK,
and in Psychiatry at the Maudsley Hospi-
tal and the Institute of Psychiatry, King’s
College, University of London, UK.
Dr. Phillips’ research focuses on using
neuroimaging techniques to discover
functional and structural abnormalities
in brain circuits for emotion processing
and regulation and reward processing
that are associated with specific psychi-
atric disorders. Her research also focuses
on identifying the neurodevelopmental
trajectories in these circuitries that are
associated with the development of such
disorders in youth and infants, and the
extent to which these neuroimaging tech-
niques can identify biomarkers reflecting
underlying processes that may increase
the future risk for these disorders in as
yet unaffected youth. Her more recent
work examines how neuromodulation
techniques can be targeted on identified
neural biomarkers of mood disorders, as
a step toward developing new interven-
tions for individuals with these disorders.
In 2017, Dr. Phillips became President
Elect of the Society of Biological Psy-
chiatry. She has served on the Member-
ship Committee of the American College
of Neuropsychopharmacology, and on
Program Committees of both the Society
of Biological Psychiatry and the Ameri-
can College of Neuropsychopharmacol-
ogy, the latter of which awarded her the
Joel Elkes Research Prize in 2014. She has
mentored over 60 junior investigators,
and has authored or co-authored more
than 300 publications.
Pittsburgh Foundation-Emmerling Endowed Chair in Psychotic Disorders
Professor in Psychiatry and Clinical Translational Science University of Pittsburgh, Western Psychiatric Institute and Clinic
Scientific Council Member
2005 Independent Investigator
Mary L. Phillips M.D., M.D. (Cantab)
“Winning this award is a huge honor, not just for me, but for all the hard working members of my research team, and my collaborators and mentors throughout the years. I am so grateful to the Brain & Behavior Research Foundation for recognizing our work, and the potential our research has to develop new and effective treatments for individuals with otherwise devastating psychiatric illnesses.”
“Robert M. Post, M.D., Chair of the Colvin Prize Selection Committee, said: “Dr. Phillips has led the field in employing state-of-art neuroimaging techniques to identify markers of reward and emotional regulation neural circuitry function and structure that characterize youth with and youth at risk of future bipolar disorder and other mood disorders, including neurobiological measures that identify at-risk youth who are most likely to develop worsening psychopathology and mood disorders in the future. She has had a substantial impact on the field of psychiatry through her research activities, her teaching and mentorship of the next generation of academic and physician scientists both nationally and internationally.”
”
COLV IN PRIZE
For Outstanding Achievement In Mood D isorders Research
16
Distinguished University Professor Department of Human Development and Quantitative Methodology Neurosciences and Cognitive Sciences Program University of Maryland, College Park
2007 Distinguished Investigator
Nathan A. Fox is a Distinguished Uni-
versity Professor in the Department of
Human Development and Quantitative
Methodology and the Neuroscience and
Cognitive Sciences Program at the Uni-
versity of Maryland. He received a bach-
elor’s degree in Political Science at Wil-
liams College and his Ph.D. in Psychology
and Social Relations from Harvard Uni-
versity, and was a Postdoctoral Fellow
in Cross-Cultural Child Development at
Harvard. He is a founding member of the
National Scientific Council for the Devel-
oping Child and currently co-Scientific
Director of this group.
Dr. Fox has completed research on the
biological bases of social and emotional
behavior, developing methods for assess-
ing brain activity in infants and young
children during tasks designed to elicit a
range of emotions. His major focus has
been on the temperament of behavioral
inhibition, which confers a risk for devel-
opment of social anxiety in children. The
research he has completed has identified
factors that either reduce the likelihood
of development of anxiety or enhance its
likelihood. This work focuses mainly on
cognitive processes and Dr. Fox uses both
behavioral tasks and electrophysiology
to assess individual differences in perfor-
mance in children.
Along with fellow 2017 Ruane Award
recipients Drs. Nelson and Zeanah, Dr.
Fox is a Principal Investigator on the
Bucharest Early Intervention Project.
This longitudinal study is the first (and
only) randomized clinical trial of foster
care intervention for infants and young
children who began life in institutions
under conditions of significant psycho-
social adversity. Drs. Fox, Nelson and
Zeanah are also the authors of Romania’s Abandoned Children: Deprivation, Brain Development and the Struggle for Recovery
(Harvard University Press, 2014).
Nathan A. Fox, Ph.D.“My career has been spent examining the factors that are asso-
ciated with the development of psychopathology in children
and adolescents. The importance of translational work cannot
be over-emphasized. I find that to be true of my temperament
work and my work on early adversity. Throughout my research
career I have been fortunate to have outstanding collabora-
tors who have made this work exciting and fun. I am thrilled
to receive this award and hope to continue my work in these
areas and the translation of this work for policy and practice
for years to come.”
“Judith L. Rapoport, M.D., Chair of the Ruane Prize Selection Committee, said the studies by Drs. Fox, Nelson and Zeanah “document the behavioral and physiological abnormalities [of the Bucharest children] and include treatment intervention studies. While their collaborative studies were of great significance, it should be noted that all three of these investigators would be strong contenders for the Ruane Prize from their other studies independent of this particular collaboration.”*
*quote directed to all three ruane prize winners
”
ruane PRIZE for Outstanding Achievement in Ch i ld & Adolescent Psychiatric Research
17
Charles A. Nelson III is a Professor of Pedi-
atrics and Neuroscience and Professor of
Psychology in the Department of Psychi-
atry at Harvard Medical School, and Pro-
fessor of Education in the Harvard Grad-
uate School of Education. He also holds
the Richard David Scott Chair in Pediat-
ric Developmental Medicine Research at
Boston Children’s Hospital, and is Direc-
tor of Research in the Division of Develop-
mental Medicine. He received his under-
graduate degree from McGill University,
master’s degrees from the University of
Wisconsin and his Ph.D. from the Univer-
sity of Kansas, all in psychology.
Dr. Nelson’s research centers on a variety
of problems in developmental cognitive
neuroscience, including the development
of social perception; developmental tra-
jectories to autism; and the effects of early
adversity on brain and behavioral devel-
opment. He chaired the John D. and Cath-
erine T. MacArthur Foundation Research
Network on Early Experience and Brain
Development, and served on the National
Academy of Sciences (NAS) panels that
wrote From Neurons to Neighborhoods, and more recently, New Directions in Child Abuse and Neglect Research
Along with fellow 2017 Ruane Award
recipients Drs. Fox and Zeanah, Dr.
Nelson is a Principal Investigator on
the Bucharest Early Intervention
Project and a co-author of Romania’s Abandoned Children: Deprivation, Brain Development and the Struggle for Recov-ery (Harvard University Press, 2014).
Among his many honors, Dr. Nelson has
received the Leon Eisenberg Award from
Harvard Medical School, an honorary
Doctorate from Bucharest University
(Romania), has been a resident fellow
at the Rockefeller Foundation Bellagio
Center (Italy), and has been elected to the
American Academy of Arts and Sciences.
Professor of Pediatrics and Neuroscience
Professor of Psychology in Psychiatry Harvard Medical School Professor of Education Harvard Graduate School of Education Richard David Scott Chair in Pediatric Developmental Medicine ResearchBoston Children’s Hospital
Charles A. Nelson III, Ph.D. “It is an incredible honor to receive this prize. I have a
long-standing interest in how early experience impacts
early brain and behavioral development. I originally exam-
ined this problem through the lens of typical development,
focusing most on the development and neural bases of face
processing. Over the years this interest expanded to include
the impact of early adversity on brain-behavioral develop-
ment; the study of infants at high risk for developing autism;
and most recently, how individual differences in processing
facial emotion in infancy are associated with later psychopa-
thology. Receipt of this award validates and affirms that the
scientific problems I have elected to address over the past
25 years are significant and have the potential to positively
impact the lives of tens of thousands of children.”
ruane PRIZE for Outstanding Achievement in Ch i ld & Adolescent Psychiatric Research
18
Mary Peters Sellars Polchow Chair in Psychiatry Vice Chair for Child and Adolescent Psychiatry Professor of Psychiatry and Pediatrics
Director of the Institute for Infant and Early Childhood Mental Health Tulane University School of Medicine
Charles H. Zeanah, Jr. is the Mary Peters
Sellars Polchow Chair in Psychiatry and
serves as Vice Chair for Child and Ado-
lescent Psychiatry, Professor of Psychi-
atry and Pediatrics, and Director of the
Institute for Infant and Early Childhood
Mental Health at the Tulane University
School of Medicine. He received his bach-
elor’s degree in English and his M.D. from
Tulane University. He completed a pediat-
ric internship at the University of Virginia,
a residency in general psychiatry at Duke
University, and a fellowship in child and
adolescent psychiatry and a research fel-
lowship at Stanford University.
Throughout his career, Dr. Zeanah has
studied the effects of adverse early
experiences, including trauma, abuse, and
neglect on young children’s development.
He has been a leader in infant mental
health, exploring attachment and attach-
ment disorders in conditions of extreme
risk. He also has studied interventions
designed to enhance recovery following
exposure to adverse experiences and has
published widely on these topics. With
fellow Ruane recipients Drs. Nelson and
Fox, he has explored the effects of severe
early deprivation on brain and behavioral
development in the Bucharest Early Inter-
vention Project, and is co-author of Roma-nia’s Abandoned Children: Deprivation, Brain Development and the Struggle for Recovery (Harvard University Press, 2014).
Dr. Zeanah has won numerous awards,
including the Irving Phillips Award for
Prevention (2006) and the Norbert and
Charlotte Rieger Award for Outstanding
Scientific Achievement (2016) from the
American Academy of Child and Adolescent
Psychiatry, the Blanche F. Ittelson Award
for Research in Child Psychiatry (2009)
and the Agnes Purcell McGavin Award for
Prevention (2015) from the American Psy-
chiatric Association, and the Serge Lebovici
Award (2010) from the World Association
for Infant Mental Health.
Charles h. Zeanah, JR., M.D.“I am deeply honored to receive the Ruane Prize with
my colleagues. Our work has examined the long-term
effects of early deprivation and factors that enhance
children’s recovery following early adversity. This work
has demonstrated the enormous potential of caregiv-
ing to alter the course of children’s development and
the urgency of providing children with experiences that
promote healthy development.”
ruane PRIZE for Outstanding Achievement in Ch i ld & Adolescent Psychiatric Research
19
Trevor W. Robbins is a Professor of
Cognitive Neuroscience at the Univer-
sity of Cambridge and Director of the
Behavioural and Clinical Neuroscience
Institute. He received his bachelor’s, mas-
ter’s, and doctoral degrees in psychology
from the University of Cambridge. He is
a Fellow for the Royal Society.
Dr. Robbins’ research integrates
approaches from cognitive and behavioral
neuroscience with psychopharmacology.
In a multi-disciplinary research program
involving both experimental animals and
human patients, he has defined cognitive
and behavioral functions of neural net-
works linking the frontal lobes to other
regions of the brain, such as the striatum,
in control of action and thought, as well
as motivation. He has been especially
interested in the way chemical systems,
including dopamine, norepinephrine, sero-
tonin, and acetylcholine, mediate states
such as mood and alertness to influence
the functioning of these networks. He also
has pursued possible drug treatments for
cognitive enhancement in patients with
psychiatric and neurodegenerative disor-
ders ranging from attention-deficit hyper-
activity disorder and schizophrenia to Alz-
heimer’s and Parkinson’s diseases.
His interest in translational research
began with his co-invention of the
CANTAB computerized neuropsycholog-
ical battery, which correlates measures of
cognitive function with neural networks,
and is currently used in more than 700
institutes and clinical centers worldwide.
Among several awards, Dr. Robbins was
the co-recipient of the Distinguished Sci-
entific Contribution Award for 2011 from
the American Psychological Association
and recipient of the Gold Medal of the
U.S. Society for Biological Psychiatry in
2017. In 2014 he shared the “Brain Prize”
of the Grete Lundbeck European Brain
Research Foundation.
Professor, Cognitive Neuroscience University of Cambridge Director Behavioural and Clinical Neuroscience Institute
Trevor W. Robbins, Ph.D.
“To receive the Patricia Goldman-Rakic Award is a very great
honor that means a lot to me—not only because of my enor-
mous admiration for Patricia and her approach to science,
which has inspired so much of my work, but also because of
her inspirational encouragement and friendship.”
Goldman-Rak ic PRIZE for Outstanding Achievement in Cogn it ive Neurosc ience
“Jack D. Barchas, M.D., Chair of the Goldman-Rakic Prize Selection Committee, said Dr. Robbins’ innovative and groundbreaking discoveries on the prefrontal cortex “have resulting in pioneering treatments relevant to various mental disorders. Like Pat Goldman-Rakic, Professor Robbins’ vigor and dedication to research and stellar productivity makes him ideal for this prize.”
”
20
prev ious outstanding achievementprizewinners
lieber prize
1987 Benjamin S. Bunney, M.D.
Yale University
1988 Philip Holzman, Ph.D.
Harvard University
1989 Timothy Crow, M.D.
Oxford University, UK
1990 Philip Seeman, M.D., Ph.D.
University of Toronto, Canada
1991 Patricia Goldman-Rakic, Ph.D.
Yale University
1992 John M. Kane, M.D.
Albert Einstein College of Medicine
Herbert Y. Meltzer, M.D.
Vanderbilt University
1993 Daniel R. Weinberger, M.D.
National Institute of Mental Health
1994 Arvid Emil Carlsson, M.D.*
University of Gothenburg, Sweden
1995 Kenneth S. Kendler, M.D.
Virginia Commonwealth University
1996 Paul Greengard, Ph.D.*
The Rockefeller University
1997 Göran C. Sedvall, M.D., Ph.D.
Karolinska Institutet, Sweden
Lars Farde, M.D., Ph.D.
Karolinska Institutet, Sweden
1998 George K. Aghajanian, M.D.
Yale University
Sarnoff A. Mednick, Ph.D.,Dr.
Med.
University of Southern California
1999 Salomon Z. Langer, Ph.D.
Compugen, Israel
Richard Jed Wyatt, M.D.
National Institute of Mental Health
2000 Nancy C. Andreasen, M.D., Ph.D. University of Iowa
William T. Carpenter, Jr., M.D.
University of Maryland
2001 Solomon H. Snyder, M.D.
The Johns Hopkins University
2002 Francine M. Benes, M.D., Ph.D.
Harvard University
2003 Robin Murray, M.D., DSc
King’s College London, Institute
of Psychiatry, UK
2004 Joseph T. Coyle, M.D.
Harvard University
2005 David A. Lewis, M.D.
University of Pittsburgh
2006 Jeffrey A. Lieberman, M.D.
Columbia University
2007 Eve C. Johnstone, M.D.
University of Edinburgh, Scotland
2008 Irving I. Gottesman, Ph.D.
University of Minnesota
2009 Raquel E. Gur, M.D., Ph.D.
University of Pennsylvania
Ruben C. Gur, Ph.D.
University of Pennsylvania
2010 Ming T. Tsuang, M.D., Ph.D., DSc.
University of California, San Diego
2011 Carol A. Tamminga, M.D.
University of Texas Southwestern
Medical Center at Dallas
Joel E. Kleinman, M.D., Ph.D.
National Institute of Mental Health
2012 Michael O’Donovan, M.D., Ph.D.
Cardiff University, Wales
Michael J. Owen, M.D., Ph.D.
Cardiff University, Wales
2013 Marc G. Caron, Ph.D.
Duke University Medical Center
2014 David L. Braff, M.D.
University of California,
San Diego School of Medicine
Patrick F. Sullivan, M.D.,
FRANZCP
Karolinska Institute, University
of North Carolina, Chapel Hill
2015 Robert Freedman, M.D.
University of Colorado, Denver
Patrick McGorry, M.D., Ph.D
FRCP, FRANCZP
Orygen and University
of Melbourne
2016 Michael F. Green, Ph.D.
Stephen R. Marder, M.D.
University of California,
Los Angeles
*Recipient of the 2000 Nobel Prize in Physiology or Medicine.
21
maltz prize
Baer Prize
2004 Jonathan Picker, M.D., Ph.D. Harvard University
2005 Takanori Hashimoto, M.D., Ph.D. University of Pittsburgh
2006 Lorna W. Role, Ph.D. Columbia University
2007 Jeremy Hall, M.D., Ph.D. Edinburgh University, Scotland
2008 Angus W. MacDonald, III, Ph.D. University of Minnesota
2009 Daniel H. Wolf, M.D., Ph.D. University of Pennsylvania
2010 Stephen J. Glatt, Ph.D. State University of New York, Upstate
2011 Elena I. Ivleva, M.D. University of Texas Southwest Medical Center
Amanda J. Law, Ph.D. National Institute of Mental Health
2012 James T. R. Walters, M.D., Ph.D. Cardiff University, Wales
2013 Kafui Dzirasa, M.D., Ph.D. Duke University
Nikhil M. Urs, Ph.D. Duke University
2014 Gregory Light, Ph.D. University of California, San Diego/
San Diego Veterans Affairs Department
Stephan Ripke, M.D. Psychiatric Genomics Consortium
2015 M. Camille Hoffman, M.D., MSCS University of Colorado, Denver
Barnaby Nelson, Ph.D. Orygen and University of Melbourne
Maltz Prize
2016 William P. Horan, Ph.D.
Amanda McCleery, Ph.D. University of California, Los Angeles
22
colvin prize
Selo Prize
1993 Robert M. Post, M.D. Pennsylvania State Hospital
1994 Jules Angst, M.D. Psychiatric University Hospital, Zurich, Switzerland
Myrna M. Weissman, Ph.D. New York State Psychiatric Institute
1995 Claude de Montigny, M.D., Ph.D. McGill University, Canada
1996 Wade Berrettini, M.D., Ph.D. University of Pennsylvania
Elliot S. Gershon, M.D. University of Chicago
J. Raymond DePaulo, Jr., M.D. The Johns Hopkins University
1997 Arthur Prange, Jr., M.D. University of North Carolna- Chapel Hill
Charles B. Nemeroff, M.D., Ph.D. Emory University
1998 Martin B. Keller, M.D. Brown University
Julien Mendlewicz, M.D., Ph.D. University of Brussels/ Erasme Hospital, Belgium
Falcone Prize
1999 Frederick K. Goodwin, M.D George Washington University
Husseini K. Manji, M.D. National Institute of Mental Health
2000 Kay Redfield Jamison, Ph.D. The Johns Hopkins University
A. John Rush, Jr., M.D. University of Texas Southwestern Medical Center at Dallas
Robert H. Belmaker, M.D. Ben-Gurion University, Israel
2001 Hagop S. Akiskal, M.D. University of California, San Diego
William E. Bunney, Jr., M.D. University of California, Irvine
2002 Ronald Duman, Ph.D. Yale University
Paul Grof, M.D., Ph.D. University of Ottawa, Canada
2003 Robert M. A. Hirschfeld, M.D. University of Texas Medical Branch, at Galveston
Ross J. Baldessarini, M.D. Harvard University
Leonardo Tondo, M.D., M.S. Cagliari University, Italy
2004 Harold A. Sackeim, Ph.D. Columbia University
Joseph R. Calabrese, M.D. Case University School of Medicine
2005 Jan A. Fawcett, M.D. University of New Mexico
Alan F. Schatzberg, M.D. Stanford University
2006 Lori L. Altshuler, M.D. University of California, Los Angeles
2007 Helen S. Mayberg, M.D. Emory University
2008 Charles L. Bowden, M.D. University of Texas Health Science Center at San Antonio
Mark S. George, M.D. Medical University of South Carolina
2009 Lewis L. Judd, M.D., DSc (Hon.) University of California, San Diego
Eric J. Nestler, M.D., Ph.D. Mount Sinai School of Medicine
Bipolar Mood Disorders Prize
2010 Lars Vedel Kessing, M.D., D.M.Sc. Copenhagen University Hospital, Rigshospitalet, in Denmark
2011 David J. Miklowitz, Ph.D. University of California, Los Angeles
Carlos A. Zarate, M.D. National Institute of Mental Health
Colvin Prize
2012 Eduard Vieta, M.D., Ph.D. University of Barcelona, Spain
Karen Dineen Wagner, M.D.,Ph.D. University of Texas Medical Branch at Galveston
2013 Boris Birmaher, M.D. University of Pittsburgh School
of Medicine
Andrew A. Nierenberg, M.D. Harvard Medical School
2014 Wayne C. Drevets, M.D. Johnson & Johnson, Inc.
Fritz A. Henn, M.D., Ph.D. Cold Spring Harbor Laboratory, Ichan School of Medicine at Mount Sinai
2015 Michael Berk, Ph.D., MBBCh, MMed, FF(Psych)SA, FRANCZP Deakin University
L. Trevor Young, M.D., Ph.D., FRCPC University of Toronto
2016 Francis J. McMahon, M.D. National Institute of Mental Health
Thomas G. Schulze, M.D. Medical Center of the University of Munich
Pamela Sklar, M.D., Ph.D. Icahn School of Medicine at Mount Sinai
23
goldman-rakic prize
2003 Solomon H. Snyder, M.D. The Johns Hopkins University
2004 Michael Posner, Ph.D. University of Oregon
Marcus Raichle, M.D. Washington University
2005 Bruce S. McEwen, Ph.D. The Rockefeller University
2006 Joaquin M. Fuster, M.D., Ph.D. University of California, Los Angeles
2007 Huda Akil, Ph.D. University of Michigan
2008 Eric J. Nestler, M.D., Ph.D. Mount Sinai School of Medicine
2009 Brenda Milner, CC, Ph.D. McGill University, Canada
2010 Robert C. Malenka, M.D., Ph.D. Stanford University
2011 Michael E. Goldberg, M.D. Columbia University/ New York State Psychiatric Institute
2012 Larry R. Squire, Ph.D. University of California, San Diego
2013 Karl Deisseroth, Ph.D. Stanford University
2014 Richard L. Huganir, Ph.D. Johns Hopkins University School of Medicine
2015 Amy F. T. Arnsten, Ph.D. Yale University
2016 Earl K. Miller, Ph.D. Massachusetts Institute of Technology
ruane prize
2000 Professor Sir Michael L. Rutter King’s College London, Institute
of Psychiatry, UK
2001 Donald J. Cohen, M.D. Yale University
2002 Judith L. Rapoport, M.D. National Institute of Mental Health
2003 Leon Eisenberg, M.D. Harvard Medical School
2004 Magda Campbell, M.D. New York University
C. Keith Conners, Ph.D. Duke University
Rachel G. Klein, Ph.D. New York University
2005 Allan L. Reiss, M.D. Stanford University
2006 David A. Brent, M.D. University of Pittsburgh School of Medicine
David Shaffer, M.D. Columbia University
2007 James F. Leckman, M.D. Yale University
2008 Eric Andrew Taylor, M.D. King’s College London, Institute of Psychiatry, UK
2009 Adrian C. Angold, M.D. Duke University Medical Center
E. Jane Costello, Ph.D. Duke University Medical Center
2010 Terrie E. Moffitt, Ph.D. Duke University King’s College London, Institute of Psychiatry, UK
Avshalom Caspi, Ph.D. Duke University King’s College London, Institute of Psychiatry, UK
2011 Daniel S. Pine, M.D. National Institute of Mental Health
2012 Daniel Geschwind, M.D., Ph.D. University of California, Los Angeles
Matthew State, M.D., Ph.D. Yale University
2013 Jay N. Giedd, M.D. National Institute of Mental Health
2014 Anita Thapar, M.D., Ph.D. Cardiff University School of Medicine
2015 BJ Casey, Ph.D. Weill Cornell Medical College
Francisco Xavier Castellanos, M.D. Child Study Center at NYU Langone Medical Center
2016 John L. R. Rubenstein, M.D., Ph.D. University of California, San Francisco
24
Scientific Council
President
Herbert Pardes, M.D.
Vice President Emeritus
Floyd E. Bloom, M.D.
Ted Abel, Ph.D.
Anissa Abi-Dargham, M.D.
Schahram Akbarian, M.D.,Ph.D.
Huda Akil, Ph.D.
Susan G. Amara, Ph.D.
Stewart A. Anderson, M.D.
Nancy C. Andreasen, M.D.,Ph.D.
Amy F.T. Arnsten, Ph.D.
Gary S. Aston-Jones, Ph.D.
Jay M. Baraban, M.D., Ph.D.
Deanna Barch, Ph.D.
Jack D. Barchas, M.D.
Samuel H. Barondes, M.D.
Carrie Bearden, Ph.D.
Francine M. Benes, M.D., Ph.D.
Karen F. Berman, M.D.
Wade H. Berrettini, M.D., Ph.D.
Randy D. Blakely, Ph.D.
Pierre Blier, M.D., Ph.D.
Hilary Blumberg, M.D.
Antonello Bonci, M.D.
Robert W. Buchanan, M.D.
Peter F. Buckley, M.D.
Ed Bullmore, Ph.D.
William E. Bunney, Jr., M.D.
Joseph D. Buxbaum, Ph.D.
William Byerley, M.D.
Ty Cannon, Ph.D.
William Carlezon, Ph.D.
Marc G. Caron, Ph.D.
William T. Carpenter, Jr., M.D.
Cameron S. Carter, M.D.
BJ Casey, Ph.D.
Bruce M. Cohen, M.D., Ph.D.
Jonathan D. Cohen, M.D., Ph.D.
Peter Jeffrey Conn, Ph.D.
Edwin Cook, M.D.
Richard Coppola, D.Sc.
Rui Costa, Ph.D., HHMI
Joseph T. Coyle, M.D.
Jacqueline N. Crawley, Ph.D.
John G. Csernansky, M.D.
Z. Jeff Daskalakis, M.D., Ph.D.
Karl Deisseroth, M.D., Ph.D.
J. Raymond DePaulo, Jr., M.D.
Ariel Y. Deutch, Ph.D.
Wayne C. Drevets, M.D.
Ronald S. Duman, Ph.D.
Stan B. Floresco, Ph.D.
Judith M. Ford, Ph.D.
Alan Frazer, Ph.D.
Robert R. Freedman, M.D.
Fred H. Gage, Ph.D.
Aurelio Galli, Ph.D.
Mark S. George, M.D.
Elliot S. Gershon, M.D.
Mark A. Geyer, Ph.D.
Jay N. Giedd, M.D.
Jay A. Gingrich, M.D., Ph.D.
David Goldman, M.D.
Joshua A. Gordon, M.D., Ph.D.
Elizabeth Gould, Ph.D.
Anthony A. Grace, Ph.D.
Paul Greengard, Ph.D.
Raquel Gur, M.D., Ph.D.
Suzanne N. Haber, Ph.D.
Philip D. Harvey, Ph.D.
Stephan Heckers, M.D.
René Hen, Ph.D.
Fritz A. Henn, M.D., Ph.D.
Takao Hensch, Ph.D.
Robert M.A. Hirschfeld, M.D.
L. Elliot Hong, M.D.
Steven E. Hyman, M.D.
Robert B. Innis, M.D., Ph.D.
Jonathan A. Javitch, M.D.,Ph.D.
Daniel C. Javitt, M.D., Ph.D.
Dilip Jeste, M.D.
Ned Kalin, M.D.
Peter W. Kalivas, Ph.D.
Eric R. Kandel, M.D.
Richard S.E. Keefe, Ph.D.
Samuel J. Keith, M.D.
Martin B. Keller, M.D.
John R. Kelsoe, M.D.
Kenneth S. Kendler, M.D.
James L. Kennedy, M.D.
Robert M. Kessler, M.D.
Mary-Claire King, Ph.D.
Rachel G. Klein, Ph.D.
John H. Krystal, M.D.
Amanda J. Law, Ph.D.
James F. Leckman, M.D.
Francis S. Lee, M.D., Ph.D.
Ellen Leibenluft, M.D.
Robert H. Lenox, M.D.
Pat Levitt, Ph.D.
David A. Lewis, M.D.
Jeffrey A. Lieberman, M.D.
Kelvin Lim, M.D.
Irwin Lucki, Ph.D.
Gary Lynch, Ph.D.
Robert C. Malenka, M.D., Ph.D.
Anil K. Malhotra, M.D.
Husseini K. Manji, M.D.,
F.R.C.P.C.
J. John Mann, M.D.
John S. March, M.D., M.P.H.
Stephen Maren, Ph.D.
Daniel Mathalon, Ph.D., M.D.
Helen S. Mayberg, M.D.
Bruce S. McEwen, Ph.D.
Ronald McKay, Ph.D.
James H. Meador-Woodruff, M.D.
Herbert Y. Meltzer, M.D.
Kathleen Merikangas, Ph.D.
Richard J. Miller, Ph.D.
Karoly Mirnics, M.D., Ph.D.
Bita Moghaddam, Ph.D.
Dennis L. Murphy, M.D.
Charles B. Nemeroff, M.D.,Ph.D.
Eric J. Nestler, M.D., Ph.D.
Andrew A. Nierenberg, M.D.
Patricio O’Donnell, M.D., Ph.D.
Dost Ongur, M.D., Ph.D.
Steven M. Paul, M.D.
Godfrey D. Pearlson,
M.A.,M.B.B.S.
Mary L. Phillips, M.D. (CANTAB)
Marina Picciotto, Ph.D.
Daniel S. Pine, M.D.
Robert M. Post, M.D.
James B. Potash, M.D., M.P.H.
Steven G. Potkin, M.D.
Pasko Rakic, M.D., Ph.D.
Judith L. Rapoport, M.D.
Perry F. Renshaw, M.D., Ph.D.,
M.B.A.
Kerry J. Ressler, M.D., Ph.D.
Victoria Risbrough, Ph.D.
Carolyn B. Robinowitz, M.D.
Bryan L. Roth, M.D., Ph.D.
Laura Rowland, Ph.D.
John L.R. Rubenstein, M.D., Ph.D.
Bernardo Sabatini, M.D.,Ph.D.
Gerard Sanacora, M.D., Ph.D.
Akira Sawa, M.D., Ph.D.
Alan F. Schatzberg, M.D.
Nina R. Schooler, Ph.D.
Robert Schwarcz, Ph.D.
Philip Seeman, M.D., Ph.D.
Yvette I. Sheline, M.D.
Pamela Sklar, M.D., Ph.D.
Solomon H. Snyder, M.D.,
D.Sc., D.Phil. (Hon. Causa)
Vikaas Sohal, M.D., Ph.D.
Matthew State, M.D.
Murray Stein, M.D., M.P.H.
John S. Strauss, M.D.
J. David Sweatt, Ph.D.
John A. Talbott, M.D.
Carol A. Tamminga, M.D.
Laurence H. Tecott, M.D.,Ph.D.
Ming T. Tsuang, M.D., Ph.D.,D.Sc.
Kay M. Tye, Ph.D.
Leslie G. Ungerleider, Ph.D.
Flora Vaccarino, M.D., Ph.D.
Rita J. Valentino, Ph.D.
Jim van Os, M.D., Ph.D.,
MRCPsych
Jeremy Veenstra-
VanderWeele, M.D.
Susan Voglmaier, M.D., Ph.D.
Nora D. Volkow, M.D.
Mark von Zastrow, M.D., Ph.D.
Karen Dineen Wagner, M.D.,Ph.D.
Daniel R. Weinberger, M.D.
Myrna M. Weissman, Ph.D.
Marina Wolf, Ph.D.
Jared W. Young, Ph.D.
L. Trevor Young, M.D., Ph.D.
Jon-Kar Zubieta, M.D., Ph.D.
Members Emeritus
George K. Aghajanian, M.D.
Dennis S. Charney, M.D.
Jan A. Fawcett, M.D.
Frederick K. Goodwin, M.D.
Lewis L. Judd, M.D.
Kenneth K. Kidd, Ph.D.
25
I congratulate the
Outstanding Achievement Prizewinners
for their research accomplishments and
I join in admiration and gratitude
for the humanitarian achievements of
Doctors Without Borders/Médecins Sans Frontières (MSF)
Steve Lieber
An Honorary Tribute to Constance Lieber
Outstanding Mental Health Advocate
Constance E. Lieber transformed her family’s experience with
significant mental illness into a life filled with meaning, purpose, and
extraordinary helpfulness. A global champion of psychiatric research
and a deeply caring and visionary philanthropist, Connie committed
her life to alleviating the suffering caused by mental illness.
Her guiding light continues to inspire us
as we work to make her dreams a reality.
With Deep Respect and Gratitude, The Pardes Humanitarian Prize Committee
In Honor of Doctors Without Borders/Médecins Sans Frontières (MSF)
2017 Pardes Humanitarian Prize in Mental Health Recipient
Your transformative work providing mental health care as an integrated
component of medical aid during natural and man-made emergencies
and chronic crises has had a lasting and profound impact on
individuals, families and the global community.
You have inspired us all to use our knowledge
towards the greater good for all humanity.
With Deep Respect The Pardes Humanitarian Prize Committee
The Essel Foundation
Congratulates the Distinguished
2017 Brain & Behavior Research Foundation
Outstanding Achievement Prizewinners and the
Pardes Humanitarian Prizewinner,
Doctors Without Borders/Médecins Sans Frontières (MSF)
Alpine Woods Capital Investors, LLC
Congratulates the 2017 Pardes Humanitarian Prizewinner
Doctors Without Borders/Médecins Sans Frontières (MSF)
and the Distinguished Scientists who are recipients of the
Brain & Behavior Research Foundation
Outstanding Achievement Prizes
Borrego Foundation
Congratulates
Doctors Without Borders/Médecins Sans Frontières (MSF)
and the
2017 Outstanding Achievement Prizewinners
Congratulations to
Doctors Without Borders/Médecins Sans Frontières (MSF)
2017 Pardes Humanitarian Prizewinner
and to the
2017 Outstanding Achievement Prizewinners
Tamar and Milton Maltz
We salute your dedication to alleviating the suffering caused by mental illness.
King & Spalding proudly supports the Brain & Behavior Research Foundation’s 30th Annual International Awards Dinner.
kslaw.com
Congratulates the recipients of the
Outstanding Achievement Prizes, the Pardes Humanitarian Prize in Mental Health, and the Brain and Behavior
Research Foundation for their extraordinary commitment in helping the
mentally ill and their loved ones by supporting scientific research.
Jack D. Barchas, MD Barklie McKee Henry Professor and Chair
Francis Lee, MD, PhD
Mortimer D. Sackler, M.D. Professor of Molecular Biology in Psychiatry ; Vice Chair, Research
GBF is a Catalyst for Transforming Youth Mental Health
GBF is proud to support the Brain & Behavior Research Foundation as they continue to invest in the pursuit
of meaningful advances and breakthroughs in scientific research through their
grants and prizes programs.
Congratulations to the 2017 Award Recipients!
Anne & Ronald Abramson
We extend our deep appreciation to the
Brain & Behavior Research Foundation
for over a quarter century of grants that lead to
advances and breakthroughs in scientific research.
Congratulations to all the prizewinners
for their outstanding achievements.
Jeffrey A. Lieberman, M.D. Chairman, Department of Psychiatry, Columbia University
Director, New York State Psychiatric Institute
Columbia Psychiatry
We extend our deep appreciation to the
Brain & Behavior Research Foundation
for over a quarter century of grants that lead to
advances and breakthroughs in scientific research.
Congratulations to Dr. Herbert Pardes on the
inaugural Pardes Humanitarian Prize.
Dr. Pardes has significantly influenced the course
of research and clinical care of mental illness.
Jeffrey A. Lieberman, M.D.Chairman, Department of Psychiatry of Columbia University
Director, New York State Psychiatric Institute
In Memory of Walter W. Bundschuh
George & Joanne Bundschuh
Thank you to John and Suzanne Golden for all you do for the Brain & Behavior
Research Foundation.
Jill and Sanford Sirulnick
Warm congratulations to the Pardes Humanitarian Prizewinner,Constance E. Lieber and to all the
Outstanding Achievement Prizewinners.Your continual dedication
and work mean much to us.
Bonnie & Alan Hammerschlag
Congratulations to the 2017 Award Recipients.
Marc Rappaport & Léa Dartevelle
In Honor of Dr. Herbert Pardes
Gerald Modell
Steven J. Corwin, M.D.President and Chief Executive Officer
and
The Board of Trustees, Physicians, Administration, and Staff of NewYork-Presbyterian Hospital
congratulate
Doctors Without Borders/Médecins Sans FrontièresBrain & Behavior Research Foundation’s
Pardes Humanitarian Prize in Mental Health Award Recipient
NYP_JournalAd_BBRF_1017.indd 1 10/6/17 4:08 PM
The Brain & Behavior Research Foundation is committed to alleviating the suffering caused by mental illness by awarding grants that will lead to advances and breakthroughs in scientific research.
90 Park Avenue, New York, NY 10016 | 646.681.4888 | bbrfoundation.org
